Fidelity Investments
GLSI icon

Fidelity Investments’s Greenwich LifeSciences GLSI Stock Holding History

Fidelity Investments’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.7K Sell
3,996
-111
-3% -$2.7K ﹤0.01% 4005
2026
Q1 		$98.7K Buy
4,107
+106
+3% +$2.77K ﹤0.01% 3802
2025
Q4 		$84.1K Buy
4,001
+1,137
+40% +$12K ﹤0.01% 3844
2025
Q3 		$28.5K Sell
2,864
-178
-6% -$2.01K ﹤0.01% 4213
2025
Q2 		$27.6K Buy
3,042
+2,579
+557% +$24.5K ﹤0.01% 4160
2025
Q1 		$4.42K Buy
463
+327
+240% +$3.96K ﹤0.01% 4737
2024
Q4 		$1.53K Sell
136
-29
-18% -$388 ﹤0.01% 4864
2024
Q3 		$2.37K Buy
165
+75
+83% +$1.11K ﹤0.01% 4777
2024
Q2 		$1.55K Hold
90
– – ﹤0.01% 4759
2024
Q1 		$1.79K Hold
90
– – ﹤0.01% 4716
2023
Q4 		$947 Sell
90
-3
-3% -$30 ﹤0.01% 4757
2023
Q3 		$822 Hold
93
– – ﹤0.01% 4669
2023
Q2 		$897 Sell
93
-22
-19% -$246 ﹤0.01% 4731
2023
Q1 		$1.58K Buy
115
+1
+0.9% +$16 ﹤0.01% 4675
2022
Q4 		$1.73K Buy
114
+21
+23% +$241 ﹤0.01% 4546
2022
Q3 		$1K Sell
93
-48
-34% -$444 ﹤0.01% 4670
2022
Q2 		$1K Buy
141
+30
+27% +$344 ﹤0.01% 4714
2022
Q1 		$2K Buy
+111
New +$2.24K ﹤0.01% 4662

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments's GLSI Position: Q2 2026 in Review

Fidelity Investments reduced its Greenwich LifeSciences (GLSI) stake by 2.7% in Q2 2026, selling an estimated $2.7K and leaving 3,996 shares worth $93.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4005.

Fidelity Investments first reported a position in GLSI in Q1 2022 and has held it in 18 quarters since. The position peaked at $98.7K in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Fidelity Investments held 3,996 shares of Greenwich LifeSciences worth $93.7K as of Q2 2026.
  • Fidelity Investments sold 111 Greenwich LifeSciences shares in Q2 2026, an estimated $2.7K.
  • Greenwich LifeSciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4005 holding.
  • Fidelity Investments first reported a position in Greenwich LifeSciences in Q1 2022 and has held it in 18 quarters since.
  • Fidelity Investments's Greenwich LifeSciences position peaked at $98.7K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.